Development of enhanced ethanol ablation as an alternative to surgery in treatment of superficial solid tumors.

Journal Article (Journal Article)

While surgery is at the foundation of cancer treatment, its access is limited in low-income countries. Here, we describe development of a low-cost alternative therapy based on intratumoral ethanol injection suitable for resource-limited settings. Although ethanol-based tumor ablation is successful in treating hepatocellular carcinomas, the necessity for multiple treatments, injection of large fluid volumes, and decreased efficacy in treatment of non-capsulated tumors limit its applicability. To address these limitations, we investigated an enhanced ethanol ablation strategy to retain ethanol within the tumor through the addition of ethyl cellulose. This increases the viscosity of injected ethanol and forms an ethanol-based gel-phase upon exposure to the aqueous tumor environment. This technique was first optimized to maximize distribution volume, using tissue-simulating phantoms. Then, chemically-induced epithelial tumors in the hamster cheek pouch were treated. As controls, pure ethanol injections of either four times or one-fourth the tumor volume induced complete regression of 33% and 0% of tumors, respectively. In contrast, ethyl cellulose-ethanol injections of one-fourth the tumor volume induced complete regression in 100% of tumors. These results contribute to proof-of-concept for enhanced ethanol ablation as a novel and effective alternative to surgery for tumor treatment, with relevance to resource-limited settings.

Full Text

Duke Authors

Cited Authors

  • Morhard, R; Nief, C; Barrero Castedo, C; Hu, F; Madonna, M; Mueller, JL; Dewhirst, MW; Katz, DF; Ramanujam, N

Published Date

  • August 18, 2017

Published In

Volume / Issue

  • 7 / 1

Start / End Page

  • 8750 -

PubMed ID

  • 28821832

Pubmed Central ID

  • PMC5562881

Electronic International Standard Serial Number (EISSN)

  • 2045-2322

Digital Object Identifier (DOI)

  • 10.1038/s41598-017-09371-2


  • eng

Conference Location

  • England